PUBLIC CONTRACT · 2020
Carfilzomib 10 mg, 30 mg, 60 mg pó sol inj fr IV
- Contract value
- €6,002.59
- Signed on
- 18 September 2020
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 7106603PUBLISHED SUBJECT
CARFILZOMIB 10 MG, 30 MG, 60 MG PÓ SOL INJ FR IV
Parties involved
- Place of performance
- Portugal, Porto, Porto
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Amgen Biofarmacêutica, Lda · Tax ID 502942959
Values and timeline
- Contract price
- €6,002.59
- Procedure base price
- €6,002.59
- Total effective price
- Not reported on Portal BASE
- Publication date
- 2 October 2020
- Award date
- 2 September 2020
- Signing date
- 18 September 2020
- Performance period
- 20 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Preço ou custo
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea c) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4840681
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.